The recent surge in UNVC appears to relate to this...
=================
Monday December 17, 11:45 am Eastern Time
Press Release
SOURCE: Univec, Inc.
TERUMO begins commercial production of the Auto-Disable Syringe Licensed by Univec, Inc. Contributing to safer injection practices
FARMINGDALE, N.Y.--(BUSINESS WIRE)--Dec. 17, 2001--Univec the Farmingdale-based UNIVEC, Inc. (OTCBB:UNVC - news), which licensed its technology to Terumo Europe N.V. is happy to share this press release from Terumo Europe N.V. indicating that Terumo Europe N.V. has launched its new Auto-Disable Syringes.
With its AD-Syringes, TERUMO contributes to safer injection practices and helps to reduce the risk of cross-contamination and injection-associated transmission of blood-borne pathogens, such as hepatitis B, hepatitis C and HIV infections. The key feature of TERUMO AD-Syringe is the locking mechanism, which locks the plunger once the syringe plunger is depressed. This means that TERUMO AD-Syringe is preventing the re-use of the syringe. With its AD-Syringes, TERUMO is answering to the joint policy statement issued by WHO, UNICEF and UNFPA, which urge all countries to use AD-syringes for administering vaccines. TERUMO AD-Syringes obtained all certifications required, complying with the WHO/V&B Performance Specification E8/ DS1 - 1 October 1999 and the European directive for medical devices MDD 93/42/ECC.
TERUMO Europe NV is an affiliate of TERUMO Corporation - Japan, a global medical technology company that develops, manufactures and markets a broad range of products and services.
(abridged)
biz.yahoo.com
=================
This is the first substantive press release from Univec in a very long time and it appears to resolve a long-standing problem of finding a reliable production facility for their syringes etc.
In the weeks leading up to this announcement the stock had become virtually worthless (trading for single pennies). I am not well informed about Univec now and cannot claim to know whether this licensing/production announcement represents a major turning point for the company and/or a significant inflection point for the stock.
A chart siliconinvestor.com |
